Cargando…
Rosuvastatin Decreases Intestinal Fatty Acid Binding Protein (I-FABP), but Does Not Alter Zonulin or Lipopolysaccharide Binding Protein (LBP) Levels, in HIV-Infected Subjects on Antiretroviral Therapy
INTRODUCTION: Altered gastrointestinal (GI) barrier integrity and subsequent microbial translocation may contribute to immune activation in HIV infection. We have reported that rosuvastatin improved several markers of immune activation in HIV+ participants, but the effect of statin treatment on mark...
Autores principales: | Funderburg, Nicholas T., Boucher, Morgan, Sattar, Abdus, Kulkarni, Manjusha, Labbato, Danielle, Kinley, Bruce I., McComsey, Grace A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Pathogens and Immunity
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4972492/ https://www.ncbi.nlm.nih.gov/pubmed/27500282 http://dx.doi.org/10.20411/pai.v1i1.124 |
Ejemplares similares
-
933. Serum Albumin Is Associated With Higher Inflammation and Carotid Atherosclerosis in Treated HIV Infection
por: Dirajlal-Fargo, Sahera, et al.
Publicado: (2018) -
Serum Albumin Is Associated With Higher Inflammation and Carotid Atherosclerosis in Treated Human Immunodeficiency Virus Infection
por: Dirajlal-Fargo, Sahera, et al.
Publicado: (2018) -
Determinants of Serum Concentrations of Lipopolysaccharide-Binding Protein (LBP) in the Adult Population: The Role of Obesity
por: Gonzalez-Quintela, Arturo, et al.
Publicado: (2013) -
Lipopolysaccharide binding protein (L.B.P.) – an inflammatory marker of prognosis in the acute appendicitis
por: Brănescu, C, et al.
Publicado: (2012) -
2′-Fluoro-Pyrimidine-Modified RNA Aptamers Specific for Lipopolysaccharide Binding Protein (LBP)
por: Aldag, Jasmin, et al.
Publicado: (2018)